Last checked at 7 Aug 2009 16:42
PLETHORA SOLUTIONS HOLDINGS PLC
Holding in Company
Plethora Solutions Holdings PLC ("Plethora" or the "Company", AIM : PLE), the specialist developer of products for the treatment and management of urological disorders, received notification on 7 August 2009 in accordance with FSA Disclosure and Transparency Rules Transitional Provisions 7, that Invesco Limited is now interested in 2,600,000 shares in Plethora, representing 8.43 per cent of the Company's issued share capital.
The Company also received notification on 7 August 2009 that Invesco English & International Trust no longer has a notifiable holding in Plethora.
Enquiries:
| Plethora Solutions Steven Powell | Tel : +44(0) 20 3077 5400 |
| FinnCap Geoff Nash | Tel: +44(0) 20 7600 1658 |
| Hansard Group Adam Reynolds/John Bick | Tel: +44(0) 20 7245 1100 |
About Plethora:
Plethora is focused on the development and marketing of products for the treatment of urological disorders. The Company has products in clinical development for the treatment of overactive bladder (PSD506), stress urinary incontinence (PSD503), interstitial cystitis (PSD597), gynaecological pain (PSD508), erectile dysfunction (PSD510) and premature ejaculation (PSD502). The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM:PLE)
Further information is available at www.plethorasolutions.co.uk